Gomekli
Generic: mirdametinib
- Manufacturer
- Novo Nordisk
- NDC
- 82448-130
- RxCUI
- 2705617
- Route
- ORAL
- ICD-10 indication
- M05.9
Affordability Check
How much will you actually pay for Gomekli?
In 30 seconds, see every legitimate way to afford Gomekli — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Gomekli
What is this medication? Ozempic is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes mellitus. It belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists, which work by mimicking the action of a natural hormone in the body. This medication helps the pancreas secrete the appropriate amount of insulin when glucose levels are high, slows the rate at which food leaves the stomach, and prevents the liver from releasing too much sugar into the bloodstream. Beyond glycemic control, Ozempic is often utilized to reduce the risk of major cardiovascular events, such as stroke or heart attack, in patients who have both type 2 diabetes and heart disease. It may also be used as part of a chronic weight management program for individuals with a high body mass index or other weight-related health conditions. The medication is usually administered via a subcutaneous injection once a week and is most effective when combined with regular physical activity and a balanced, low-calorie diet.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per 21-day supply
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Must have commercial health insurance; intended for US audiences; not valid for patients with government-funded insurance (e.g., Medicare, Medicaid)
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for mirdametinib.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Gomekli →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for mirdametinib →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Medicare Part D coverage
How Gomekli appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).
Covered by plans
69%
3,815 of 5,499 plans
Most common tier
Tier 5
On 79% of covering formularies
Prior authorization required
99%
of covering formularies
| Tier | Formularies on this tier | Share |
|---|---|---|
| Tier 1 (preferred generic) | 59 | 18% |
| Tier 2 (generic) | 2 | 1% |
| Tier 4 (non-preferred brand) | 7 | 2% |
| Tier 5 (specialty) | 259 | 79% |
| Tier 6 | 1 | 0% |
Step therapy: 0% of formularies
Quantity limits: 82% of formularies
Coverage breadth: 328 of 65 formularies
How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
Oxygen/Nitrogen 40/60
Treats same condition · Oxygen/Nitrogen 40/60
INDOMETHACIN
Treats same condition · Indomethacin
Diflunisal
Treats same condition · Diflunisal
Diclofenac DR
Treats same condition · Diclofenac
Physician EZ Use Joint Tunnel and Trigger Kit
Treats same condition · AMMONIA, LIDOCAINE HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, POVIDONE-IODINE
Prednisolone Sodium Phosphate Oral Solution
Treats same condition · prednisoLONE sodium phosphate
JYLAMVO
Treats same condition · Methotrexate
Diclofenac Sodium and Misoprostol
Treats same condition · Diclofenac Sodium and Misoprostol
SOVUNA
Treats same condition · Hydroxychloroquine Sulfate
Marbeta L Kit
Treats same condition · Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
Gomekli treats a rare condition. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.